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Abstract
Using the crystal structure of the uracil transporter UraA of Escherichia coli, we constructed a 3D model of the Aspergillus
nidulans uric acid-xanthine/H+ symporter UapA, which is a prototype member of the Nucleobase-Ascorbate Transporter
(NAT) family. The model consists of 14 transmembrane segments (TMSs) divided into a core and a gate domain, the later
being distinctly different from that of UraA. By implementing Molecular Mechanics (MM) simulations and quantitative
structure-activity relationship (SAR) approaches, we propose a model for the xanthine-UapA complex where the substrate
binding site is formed by the polar side chains of residues E356 (TMS8) and Q408 (TMS10) and the backbones of A407
(TMS10) and F155 (TMS3). In addition, our model shows several polar interactions between TMS1-TMS10, TMS1-TMS3,
TMS8-TMS10, which seem critical for UapA transport activity. Using extensive docking calculations we identify a cytoplasm-
facing substrate trajectory (D360, A363, G411, T416, R417, V463 and A469) connecting the proposed substrate binding site
with the cytoplasm, as well as, a possible outward-facing gate leading towards the substrate major binding site. Most
importantly, re-evaluation of the plethora of available and analysis of a number of herein constructed UapA mutations
strongly supports the UapA structural model. Furthermore, modeling and docking approaches with mammalian NAT
homologues provided a molecular rationale on how specificity in this family of carriers might be determined, and further
support the importance of selectivity gates acting independently from the major central substrate binding site.
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Introduction
The Nucleobase-Ascorbate Transporter (NATs) family, also
called Nucleobase-Cation Symporter-2 (NCS2) family, is one of
the most conserved carrier families, including hundreds of
members in all organisms, prominent exceptions being Saccharo-
myces cerevisiae and protozoa [1,2]. The function and specificity of
nearly 20 NAT proteins, coming from bacteria, fungi, plants and
mammals, is presently known, showing that most of them are
specific for the symport of xanthine, uric acid or uracil with H+. In
primates however, NAT homologues (SVCT1 and SVCT2) are
specific for the co-transport of L-ascorbic acid/Na+ [1,2].
Interestingly, none of the known NATs can recognise salvageable
purines (adenine, guanine or hypoxanthine), cytosine or nucleo-
sides. While in microorganisms NATs are not essential for life,
serving mostly as nutrient scavengers for nucleobases, their
function is necessary for normal growth and survival in plants
and mammals [3,4].
The UapA transporter of the filamentous ascomycetes Aspergillus
nidulans is the prototype member of the NAT family, being one of
the most extensively studied eukaryotic carriers with respect to
regulation of expression and structure–function relationships. This
is not only because of historical reasons, as uapA was among the
first eukaryotic transporter genes identified genetically [5] and
cloned [6,7] but mainly due to the fact that uapA mutants can be
easily selected or constructed through classical or reverse genetics,
and subsequently analysed biochemically in great detail with
simple kinetic studies. The wild-type transporter was shown to be
highly specific for the uptake of xanthine and uric acid, as both
substrates are recognised with high affinity (7–8 mM) and
transported with high capacity [8–10]. In addition, several
analogues of xanthine or uric acid, especially those that do not
have modifications in positions N1-H, N7-H or N9 of the purine
ring, were shown to act as substrates or ligands, albeit with lower
affinity [10,11]. Through the analysis of more than a hundred
UapA mutants, especially those affecting the specificity or the
transport kinetics, the functional importance of several residues
has been established [1,2,12,13]. Four absolutely conserved amino
acid residues (Q85, E356, D388 and N409) are irreplaceable for
function. Among these residues, E356 was proposed to form direct
contacts with the purine ring, based on the fact that a specific
mutation (E356D) dramatically increases the binding of physio-
logical substrates but reduces their transport [11]. A second
partially conserved amino acid, Q408, was also proposed to be
involved in direct contacts with substrates, because its substitution
with Pro dramatically reduces binding of the physiological
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substrates, but mostly because its substitution with Glu offers
UapA the capability of recognizing novel substrates, such as
hypoxanthine and guanine [9]. Furthermore, a kinetic analysis
using several xanthine analogues as competitive inhibitors of
xanthine uptake suggested that E356 and Q408 might interact
with N1H and N9 or N7H of the purine ring [11]. Four additional
absolutely or partially conserved residues, H86, G411, T417,
R418, were also shown to be crucial for determining the transport
activity of UapA [9,10,14]. Importantly, reverse genetics and Cys-
scanning mutational analysis of the homologous XanQ xanthine
transporter of Escherichia coli showed that the same residues as those
found essential for UapA function are also critical for the activity
of the bacterial carrier [15–18]. Most interestingly, randomly
selected specificity mutations enlarging the substrate profile of
UapA concerned nine partially or non-conserved residues, namely
N71, Q113, F406, A441, V463, A469, R481, T526 and F528,
distributed in several regions of UapA structure [11,12,19,20].
None of these residues was however critical for the binding and
transport efficiency of the physiological substrates of UapA.
The crystallization of the first NAT homologue from Escherichia
coli, the uracil transporter UraA [21], allowed us to build a
preliminary topological model of UapA and to verify the topology
of the residues affecting UapA function and specificity [13]. The
3D model of UapA corresponds to a cytoplasm-facing conformer
made of 14 transmembrane segments (TMSs) divided into two
inverted repeats (TMS1–7 and TMS8–14). The structure is
spatially arranged into a core and a gate domain, consisting of
TMS1–4/8–11 and TMS5–7/12–14, respectively. All residues
essential or critical for UapA function fall within TMS1, TMS3
and TMS10 in the core domain. More importantly, residues E356
(TMS8) and Q408 (TMS10) in UapA correspond to residues E241
and E290 in UraA, which were shown to interact with the uracil.
The UapA model also revealed putative critical interactions of
TMS1 with both TMS3 and TMS10. The importance of TMS3
and the interaction of TMS1 with TMS3 were genetically
supported by characterising second-site suppressors of the H86D
mutation (TMS1), which are located in M151 (TMS3). Thus, both
in UraA and UapA the substrate binding site seems to be built by
specific residues in TMS3, TMS8 and TMS10. A similar
conclusion was drawn by a recently published 3D model of the
XanQ permease [22]. Interestingly, the preliminary UapA model
also confirmed that all specificity mutations which do not affect the
kinetics of transport of physiological substrates are located
distantly from the proposed binding site, that is, outside TMS1,
TMS3, TMS8 and TMS10. This observation is in line with our
previous proposals that specificity mutations define elements of
selectivity filters or dynamic gates which allow or restrict the access
of substrates to the actual binding site [11,12,19,20].
In this work, we propose a structural model of UapA, through
the implementation of a variety of computational methodologies.
In addition, the construction and analysis of a number of rationally
designed mutations was carried out, in order to gain further insight
into the role of the various elements that constitute functional
determinants of UapA. The group of residues experimentally
characterized as critical for UapA function and specificity was
identified and their role in substrate binding and transport was
addressed in terms of structure as well as dynamics. The role of the
functionally irreplaceable residues E356 and Q408 as the main
interacting partners of the various UapA substrates was confirmed.
A quantitative structure-activity relationship (SAR) model com-
prised by an extended set of UapA substrate analogues was
constructed. The SAR model was in full agreement with our
previous genetic and biochemical studies. Furthermore, advanced
molecular simulations outlined a possible translocation mechanism
for the physiological substrate by providing a trajectory-like
displacement of xanthine across the protein and towards its
cytoplasmic side. Possible selectivity gates at the outward and
inward ends of the substrate translocation pathway are also
proposed. We finally discuss the possible role of residues in the
major binding site with respect to the specificity shift from
nucleobases to ascorbate in members of the NAT family.
Results and Discussion
A UapA Structural Model
The construction of a structural model of UapA became
possible by the recent release of the crystal structure of UraA of E.
coli [13,21]. The two proteins share a rather moderate sequence
similarity (23% identity, 41% positives), which is however
adequate for sustaining a theoretical model of UapA, especially
if combined with the plethora of the existing experimental data.
The model built here was based on the multiple alignment of the
NAT proteins of know function and specificity which was further
modified manually so that it accommodates the correct version of
UapA primary sequence (Uniprot accession number Q07307,
replacing erroneous sequences CBF71770.1 and EAA57687.1)
(Figure 1). Model building was performed using MODELLER
software. This algorithm has been used recently with success for
the norepinephrine transporter NET [23]. The loop refinement
routine and a slow simulated annealing protocol for model
refinement were implemented and 40 models were obtained. The
structure with the optimal objective function was selected for
further validation. As a first validation of the model, the structure
with the best spatial restraints score was subjected to a 50 ns
molecular dynamics run using Desmond software [24]. The system
was prepared by embedding the protein in a POPC lipid bilayer
and solvating the membrane by explicit water. The RMS
deviation of the Ca-carbons of all Helices, from starting
coordinates was monitored throughout the simulation and did
not exceed 3.0 A˚, thus indicating the stability of the theoretical
model (Figure S1).
The overall 3D structure of the UapA model (Figure 2)
corresponds to a cytoplasm-facing conformer made of 14
transmembrane segments (TMSs) that adopt a mostly helical
secondary structure. The architecture of the transporter divides
it in two distinct subdomains, the core which consists of TM
segments 1–4 and 8–11 and the gate consisting of segments 5–7
and 12–14. The transmembrane helices are connected by large
loops, the majority of which notably corresponds to lengthy
insertions in the sequence alignment, thus posing an additional
difficulty in obtaining an accurate conformational representation
for this part of the transporter. The distribution of the ionized
residues on the protein surface is fairly reasonable, as most of
them are positioned either at the cytoplasmic and periplasmic
sides or along the protein pore in the protein interior. Positive
charges are mostly concentrated in the cytoplasm-facing loops.
Genetic Support for the UapA Model
The topology of residues found to be crucial for UapA function
through physiological, cellular and kinetic analyses of relevant
mutants is indicated in Figures 1 and 2 and information on them is
summarized in Table 1. The overall picture is that critical residues
in terms of substrate binding and transport are positioned in good
accordance with existing genetic and biochemical data. All
residues so far identified as essential or critical for UapA function
are located within TMSs 1, 3, 8 and 10 of the core domain.
More specifically, the NAT signature motif Q/E/P-N-X-G-X4-T
(Q408N409N410G411X4T
416 R417 in UapA), which was proposed by
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functional studies to be an essential element for substrate
recognition and transport, is located on TMS10 in a small 9-
residue helix opposite TMS8, at the interface between the two
protein subdomains (see Figure 2C). The importance of the NAT
motif is dual. First, Q408 is directly involved in substrate binding,
as strongly suggested by functional studies [9] its alignment with
Figure 1. Multiple alignment of UapA, UraA and NAT homologues of know function and specificity, used for UapA modeled
structure. Putative transmembrane segments (TMS) of UapA are denoted in colored cylinders. TMSs forming short b-sheets are shown with arrows.
a stands for a-helical segments. Invariant and highly conserved amino acids are shaded in red and blue-lined boxes, respectively. Amino acids critical
for function and specificity discussed in the text are highlighted with asterisks: red for residues of the substrate binding site, orange for those located
in the substrate translocation pathway, green for aminoacids enlarging specificity and black for other important residues involved in dynamic
interactions of TMSs. The listed NAT homologues include: UapA of Aspergillus nidulans, GI: 88984992; UapC of Aspergillus nidulans, GI: 790973; Lpe1 of
Zea mays, GI: 162462794; SNBT1 of Rattus norvegicus, GI: 284010030; SVCT1 of Homo sapiens, GI: 6652824; SVCT2 of Homo sapiens, GI: 6048257; XanQ
of Escherichia coli, GI: 161784262; XanP of Escherichia coli, GI: 84028014; YgfU of Escherichia coli, GI: 85675700; PucJ of Bacillus subtilis, GI: 16080296;
UraA of Escherichia coli, GI: 187775829; PyrP of Lactococcus lactis, GI: 15673585 and RutG of Escherichia coli, GI:89107857.
doi:10.1371/journal.pone.0041939.g001
Figure 2. Theoretical structure of UapA. (A) Modeled 3D structure of the UapA validated with molecular dynamics using Desmond software. (B)
Top view of UapA model, indicating core (TMS1–4, 8–11)/gate (TMS5–7, 12–14) domains and TMS numbering. (C) Side view of UapA structure
showing the topology of residues selected as crucial for the function (Q85, H86, E356, A363, Q408, N409, G411, T416, R417) and specificity (Q113,
R481, T526, F528) of UapA. (D) Detailed view of dynamic interactions between TMS1 (Q85, H86), TMS8 (D360) and TMS10 (N409, T416). TMS14 is also
shown to highlight the position of residues T526 and F528, which are mostly critical for UapA specificity, in respect to all other important residues in
TMS1, TMS8 and TMS10, involved in substrate binding and transport. In (a), (c) and (d) the upper part of the figure is outward-facing and the lower
part is cytoplasmic-facing.
doi:10.1371/journal.pone.0041939.g002
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E290 which is a residue interacting with substrate in UraA [21],
and from docking studies performed herein (see later). Second,
N409, N410 and T416 seem to be involved in the stabilization of
the protein tertiary intra-subdomain structure. More specifically,
according to the model, a network of hydrogen bonds is formed
between the side-chains of N409, H86, Q85 and T416 facilitating
the interaction of TMS1 and TMS10, both belonging to the core
subdomain (see Figure 2C, 2D). Experimental support for dynamic
intramolecular interactions between these residues comes from the
fact that substitution of any of the four residues confers
cryosensitivity to UapA transport activity. Furthermore, most
substitutions of these residues lead to a dramatic reduction in Vm,
but do not affect Km values or the localization of UapA into the
plasma membrane [9,14]. A similar network is comprised by the
side-chains of N410, T405 and D360, possibly strengthening the
interaction between TMS8 and TMS10, which also belong to the
protein core. Furthermore, the UapA model also revealed putative
critical interactions of TMS1 with both TMS3 and TMS10. The
importance of TMS3 (residues F155 and S154) and its interaction
with TMS1 were genetically supported by functional studies of
relevant mutants and by second-site suppressors of the H86D
(TMS1) mutation, which are located in M151 (TMS3) [13].
Finally, residue E356 in UapA, which previous functional studies
[11] and docking studies performed herein (see later) show that is
the second major residue involved in direct interactions with
xanthine (see below), aligns perfectly with E241 in the UraA
structure, which is a residue shown directly to interact with the
substrate. Significantly, an homology model of the structure of the
XanQ permease in E. coli has also shown that functional mutations
map in TMS1, TMS3, TMS8 and TMS10 [22]. Thus, functional
studies in two evolutionary very distant homologous transporters,
such as UapA and XanQ, validate the details of the crystal
structure of UraA and the modeled structures of UapA and XanQ,
especially as far as it concerns the substrate binding site.
Interestingly, in UapA, elements distinct from the binding site,
located in the C-terminal part of the protein (TMS12–TMS14)
and in the TMS1–2 loop (see Figure 2C), were shown to control
substrate specificity, thus supporting the idea that NATs consist of
two topologically and functionally distinct structural folds, the core
and the gate domain, as this was proposed for the UraA structure
[21]. This observation also formed the basis of our previous
proposal which stated that specificity mutations define distinct
selectivity filters or dynamic gates which allow or restrict the access
of substrates to the actual binding site (see also later). Noteworthy,
UapA and XanQ/UraA have significant structural differences in
their gating domains, which is reflected in genetic and functional
differences [11,20,25]. This is highlighted by mutations in TMS14
concerning residues T526 and F528 in UapA, which correspond
to N430 and Ile432 in XanQ. In particular, while T526 and F528
mutations enlarge dramatically the specificity of UapA, the
analogous mutations in XanQ affect mostly the transport kinetics
in respect to the physiological substrate xanthine and much less the
specificity for certain xanthine analogues with bulky substitutions.
This observation suggests that in the course of evolution UapA has
acquired a more flexible gating domain, a hypothesis in line with a
significant longer TMS13–TMS14 in UapA compared to XanQ.
Substrate Docking Leads to a Model for Xanthine-UapA
Interactions
A major objective of the present study was the elucidation of the
recognition process between UapA and its physiological substrates
and their subsequent translocation along the transporter pore. To
this respect two objectives were pursued. The first was the
determination of the role played by residues which have been
identified through genetic studies as critical for interacting with the
physiological substrate. The second was the construction of a
structure-activity relationship hypothesis based on those results,
which could in turn facilitate the design of compounds that by
competing with the physiological substrates could act as inhibitors
with potential medical importance. To approach the issues of
substrate recognition and translocation, a model of the interaction
between UapA and xanthine was created using docking-scoring
calculations and the structure of UapA as derived from homology.
Docking calculations were performed using two distinct docking
protocols, a protocol based on the mixed low-mode/Monte Carlo
sampling algorithm for flexible docking and the Induced Fit
Docking protocol (IFD) as introduced by Schrodinger 2011 Suite
of programs. The IFD protocol is based on an iterative
implementation of Glide algorithm for rigid docking and Prime
algorithm for protein refinement, resulting in an improved
simulation of binding in terms of protein flexibility. This allows
for a highly efficient and sophisticated compromise of docking
speed and binding accuracy. Furthermore, since Prime is a
modeling tool especially developed for refinement of protein
structures derived by homology, its implementation as part of the
IFD protocol was considered in the case of UapA as promising
since it represented an approach complementary to the classical
low-mode/Monte Carlo where the protein is modeled as flexible.
An additional issue that was addressed concerned the tautomerism
of xanthine. In neutral pH xanthine adopts two dominant, almost
equally populated tautomeric states [26] which however introduce
a key difference to the hydrogen bond properties of each isomer.
The different protonation states of N7 and N9 and the
corresponding tautomers are denoted as Xan7H and Xan9H
respectively.
Docking results were fairly consistent with genetic data however
relatively inconclusive in suggesting a unique binding mode for
xanthine. Two different docking poses were obtained as lowest
energy structures for each tautomer, poses 3A and 3B for the
UapA-Xan7H complex and poses 3C and 3D for the UapA-
Xan9H complex (Figure 3). In pose 3A Xan7 is stabilized in the
protein substrate binding domain by 5 hydrogen bonds. In that
pose Q408 plays a key role in binding, in good agreement with
data suggesting a direct contribution of that residue to substrate
recognition [9,11]. The aforementioned hydrogen bond which is
formed between Q408 side chain amide and xanthine is also
present in pose 3C describing the UapA-Xan9 interaction. Yet,
while in pose 3A the binding partners of Q408 are the NH at
position 1 and the carbonyl at position 2 of Xan7H purine ring, in
pose 3C the respective interaction sites are NH at position 1 and
the carbonyl at position 6 of Xan9H. Genetic data have denoted
the carboxylate of E356 as an essential element in protein
recognition [11]. Docking results were in accordance with these
data as it was shown that this residue interacts through a hydrogen
bond with the NH at either position 7 of Xan7H or position 9 of
Xan9H and possibly influences the orientation of the ligand inside
the protein binding pocket (Figure 3). Two additional interactions
further contribute to the stabilization of the complexes, the
interaction between the backbone NH of A407 and either 6-
carbonyl (Xan7H) or 2-carbonyl (Xan9H) and the interaction
between the backbone carbonyl of F155 and either N9 of Xan7H
or N7 of Xan9H. In pose 3B of the UapA-Xan7 complex, the
substrate is also anchored through 5 hydrogen bonds. In that
geometry Q408 interacts with the N3H and N9 of the purine while
E356 interacts with NH1. Finally, in pose 3D the UapA-Xan9H is
stabilized by 4 hydrogen bonds, where Q408 contributes only one
hydrogen bond while E356 interacts with the N1H of xanthine.
Interestingly, the interaction between A407 and F155 backbone
Substrate Translocation Trajectory in UapA
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and the substrate is conserved in all four poses with small
variations on the xanthine interaction partners. An additional
favourable interaction which was commonly present in all four
binding orientations was the p-p stacking of the electron-rich
purine system between the side-chains of F406 and F460.
To further explore the conformational space of the UapA-
xanthine complex and evaluate the convergence of the IFD
protocol, fully flexible docking calculations were undertaken using
the low mode/Monte Carlo sampling method. The results from
the IFD calculations were used as starting structures. The
consistency between the two methodologies was fair. In the case
of tautomer Xan7H, the global minimum structure of the UapA
complex was identical to pose 3A originating from IFD
calculations. However, the global minimum structure of Xan9H
inside the binding pocket was not close to poses derived from IFD
calculations, and lacked specific interactions with the protein.
Thus, while docking calculations have provided a rich insight to
the recognition process which was in full consistency with genetic
data, they were inconclusive in determining the dominant binding
geometry out of the four possible Xan orientations and/or
protonations.
SAR Confirms the Mode of Xanthine Binding to UapA
To further check the consistency of the four different binding
modes of Xan with all existing experimental data, we attempt the
creation of quantitative Structure Activity Relationship (SAR)
models by considering a small set of xanthine analogues with
known free energy of binding (Figure 4A). For that purpose, the
iterative docking-scoring methodology of PrGen 2.1 software was
used [27]. Theoretical binding affinities (Ebinding) were estimated
by evaluating ligand-receptor interaction energies, ligand desolva-
tion energies and changes in both ligand-internal energy and
ligand internal entropy upon receptor binding (see Materials and
methods). Calculated free energies DGupred were then obtained by
linear regression between experimental free energy DGuexp and
Ebinding. A training set of seven xanthine analogues was used
(XAN, 2SX, 6SX, 3MX, 8MX, 9MX, 8AX) and four different
models were created by superimposing all ligands to each of the
four poses of xanthine, using for each analogue the appropriate
tautomer. Xanthine analogues showing a very low binding affinity,
such as 1-methylxanthine and hypoxanthine were excluded from
the training set, but retained as test set. The quality of each model
was evaluated by the coefficient of determination r2 for the
correlation between experimental and predicted DGuand the
degree of deviation from Xan orientation. While models 3A and
Table 1. Summary of residues critical for UapA function and specificity.
Allele Location
Core
Domain
Gate
Domain
Effect on transport
capacity1
Major Substrate
binding site
Trajectory (t)
or Gate (g)
Enlarged
specificity
Critical polar
interactions
Q85 TMS1 + 2 + 2 2 2 T416
H86 TMS1 + 2 + 2 2 2 N409
Q113 TMS1–2 loop + 2 + or 2 2 2 yes 2
M151 B3/TMS3 + 2 +/2 2 2 2 2
S154 TMS3 + 2 +/2 2 2 2 2
F155 TMS3 + 2 2 yes2 2 2 2
E356 TMS8 + 2 + yes 2 2 2
D360 TMS8 + 2 + 2 t 2 T405, N410
A363 TMS8 + 2 2 2 t 2 2
F406 B10/TMS10 + 2 2 2 2 yes
A407 TMS10 + 2 + yes2 2 2 2
Q408 TMS10 + 2 + yes 2 yes3 2
N409 TMS10 + 2 + 2 2 2 H86
G411 TMS10 + 2 + or 2 2 t 2 2
T416 TMS10 + 2 2 2 t 2 Q85
R417 TMS10 + 2 2 2 t 2 2
A441 TMS11–12 loop 2 + 2 2 2 yes 2
V463 TMS12 2 + 2 2 t yes 2
A469 TMS12 2 + 2 2 t yes 2
R481 TMS13 2 + 2 2 2 yes 2
T526 TMS14 2 + 2 2 g yes 2
G527 TMS14 2 + + 2 g yes 2
F528 TMS14 2 + 2 2 g yes 2
TMS: transmembrane segment.
B: beta sheet conformation within the TMS.
1‘‘2’’: no major effect on Vmax .50%, ‘‘+’’: major effect on Vmax ,10%, ‘‘+/2’’: Vmax ,30% and ‘‘+ or 2‘‘: depending on specific substitution.
2Evidence for involvement in substrate binding through peptide backbone interactions, as shown by docking. Consequently mutations with relatively small amino acids
do not have an effect.
3Q408E, confers ability to bind hypoxanthine and guanine, but does not lead to their transport. Q408 in combination with gate mutations leads to high-medium affinity
binding and transporter of all purines and uracil.
doi:10.1371/journal.pone.0041939.t001
Substrate Translocation Trajectory in UapA
PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e41939
3C demonstrated a satisfactory correlation (r2 of 0.958 and 0.964
respectively), a poor r2 was determined for models 3B and 3D
(0.567 and 0.473).
In model 3A the good correlation (Figure 4B) was accompanied
by docking poses (Figure 4C) of the different analogues that were
in agreement with the pose of xanthine, while a repositioning of all
analogues with respect to starting pose was evident in model 3B. It
is considered that the high degree of structural similarity between
Xan and the selected analogues introduces the necessity of an
equally high degree of alignment of the purine scaffold within the
binding cavity. Thus, model 3A was selected as the consensus of all
three approaches utilized. Model 3A was further validated by
calculating the binding energy of the test set. Calculated binding
energies using Prgen software showed that their binding affinity
was higher than 24.3 Kcal/mol, which is in good agreement with
experimental values.
Functional Studies Validate the Proposed Xanthine-UapA
Interaction
Model 3A could very well explain the substrate specificity
profile of UapA. 3-methylxanthine (3MX), which is a good ligand,
is positioned very similar to xanthine (XAN) (Figure S2A). The
methyl group is placed near the phenyl group of F155 forming
Figure 3. UapA – substrate interactions. Schematic representation of the four different docking poses (A–D) of xanthine-UapA interactions
(models 1–4 accordingly). Poses (A) and (B) show the modeled UapA-Xan7H complex and poses (C) and (D) the modeled UapA-Xan9H complex. The
most favoured model is shown framed and in bigger scale (A). This model was supported by docking using mixed low-mode/Monte Carlo sampling
algorithm for flexible docking and the Induced Fit Docking protocol (IFD), as well as, SAR.
doi:10.1371/journal.pone.0041939.g003
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weak Van der Waals interactions. 8-methylxanthine (8MX) is a
moderate binder, showing steric hindrance with the methyl group
of the side chain of T404 and the carboxyl group of E356 lowering
the binding affinity compared to XAN. The hydrogen bond
between N7-H and COOHE356 still exists but is weaker (Figure
S2B). 9-methylxanthine (9MX) (Figure S2C) shows moderate
binding affinity too, as the methyl group is placed close to the NH
group of the backbone of F155 disrupting the N9-NHF155 H-bond.
1-methylxanthine (1MX), which is a non-binder, is considerably
displaced, lacking interaction with Q408 and E356 (Figure S2D).
2-thioxanthine (2SX) is better binder compared to 6-thioxanthine
(6SX) (Figure S2E–S2F). The C = S bond is longer than C = O,
displacing substrate 2SX towards E356 while 6SX is displaced in
opposite direction, towards F155. Thus, 2SX forms most of the
interactions found in XAN, (however the sulphur-containing
hydrogen bond is weaker compared to the oxygen one [28]), while
6SX lacks H-bond with E356. 8-azaxanthine (8AX) although is
positioned identical to XAN (Figure S2G), is a weak binder,
probably because of the stereoelectronic properties of the N-N = N
group, preventing the way in and/or the translocation through the
transporter. Finally hypoxanthine (HX) cannot form hydrogen
bond with Q408 and E356 on the same time and thus is totally
displaced inside the binding cavity compared to XAN (Figure
S2H). Additionally docking calculations were performed for
purines not recognized by the wild-type UapA, such as guanine
and adenine taking into account their different tautomeric states.
In both cases the Q408 amide failed to form bidentate hydrogen
bond with the substrate, resulting in fewer H bond interactions
compared to XAN (Figure S2I–S2J).
In line with this model, residues Q408 and E356 are absolutely
necessary for substrate binding and transport (even the most
conserved substitutions Q408E and E356D lead to dramatic loss of
transport activity), while residues A407 and F155 can be
functionally replaced [9,11,13]. Further evidence for the direct
involvement of Q408 and E356 in substrate binding comes from
the fact that the mutation Q408 confers the ability for binding
novel substrates (hypoxanthine and guanine) and mutation E356D
leads to 18-fold increased affinity for xanthine but abolishes
transport. This last finding should be emphasized as it provides
indications which might sustain a hypothesis about the role of
E356 not only to direct substrate binding but to the dynamics of
the inward-outward transporter transition, as well. Flexible
docking calculations of XAN to the E356D-UapA, clearly
demonstrated that although of minor influence in terms of
physicochemical properties and interaction profile, the mutation
of glutamate to an aspartate 2-thioxanthine is however critical with
respect to the directional flexibility of the side chain involved. The
shorter side chain of D356 poses a serious limitation to the
conformational space accessible by the carboxylate functionality
compared to the wild type protein. This constraint acts
synergistically with the highly ordered assembly of the three
residues that are engaged in the interaction with the pyrimidine
ring of xanthine. As a result, the concurrent and finely tuned
anchoring of xanthine to all four interaction partners F155, E356,
A407 and Q408 through H-bonds is no longer feasible as a
consequence of the reduced conformational flexibility of the latter.
It can be speculated that a failure in the formation of a stable and
optimally equilibrated complex could negatively affect the
energetics of the conformational shift and thus lead to perturbed
transporter functionality as was experimentally determined for this
mutant. A mechanistic explanation for that perturbation might
involve the interaction of E356 with residues located across the
pore, its role as a mediator of the sliding of xanthine towards D360
and most importantly its possible functionality at the proton
symport cascade. As a summary, we speculate that the shorter
side-chain of D356 reduces its capacity to interact with the
substrate, as clearly shown in docking results where no acceptable
pose of xanthine directly bound to D356 was found. That in turn
might negatively influence the transition from an outward-to an
inward-facing conformation necessary for transport catalysis
[29,30]. Indirect support for this speculation comes from the fact
purified UapA-E356D protein is significantly more stable than the
wild-type protein [31].
Identification and Genetic Support of a Cytoplasm-facing
Substrate Trajectory
Apart from predicting the binding mode of xanthine, another
challenging aspect when studying a transporter is to predict the
trajectory path of the substrate. Flexible docking calculations were
chosen for this study, since they can randomly position the ligand
inside the binding pocket using specific rotational and translational
algorithm. The conformational space of the complex was
Figure 4. Structure Activity Relationship (SAR) model for the
interaction of UapA with xanthine analogues. (A) Structures of
XAN analogues used for model creation. (B) Predicted VS Experimental
DGbinding. (C) Superposition of XAN analogues inside binding domain of
UapA as proposed by final model.
doi:10.1371/journal.pone.0041939.g004
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extensively sampled by using the Monte Carlo and Low Mode
conformational search algorithm. This method has proven highly
efficient in sampling similar systems and it is considered as a robust
technique [32]. Starting from the binding pocket previously
originated xanthine was placed about 6 and 12 A˚ along the
channel formed by TMSs 8, 10 and 12 on both directions
producing 5 initial structures for docking calculations. 5000 steps
of Monte Carlo/Low Mode were produced for each run, followed
by energy minimization. During Monte Carlo perturbation the
ligand was free to move along the x, y, z axes from 0 to 5 A˚ and
simultaneous free rotation. The lowest energetically structures
obtained are depicted on Figure 5 providing a theoretical pathway
of the ligand before and after the binding pocket.
The proposed substrate translocation pathway starts from the
centrally located major substrate binding site (residues F155, E356,
A407 and Q408) and is followed by subsequent poses of xanthine
docking towards the cytoplasmic face of the transporter, close to
residues D360, A363, G411, T416, R417, V463 and A469
(Figure 5).
D360, which is a very well conserved residue in NATs, has not
been mutated before. However, the equivalent Asp in XanQ was
shown to be absolutely necessary for xanthine transport [22] and
in UraA it corresponds to H245, a residue speculatively proposed
to be important for a proton-coupled mechanism of transport of
Uracil [21]. We mutated Asp360 to Ala and His. D360H scored as
a total loss-of-function mutation (Figure 6A, 6C) and despite being
localized in the plasma membrane showed increased levels of
vacuolar turnover (Figure 6B). D360A was relatively stably
localized in the plasma membrane (Figure 6B), but conserved
low transport activity, mostly at 37uC (Figure 6A, 6C). Interest-
ingly, the low transport activity of UapA-D360A was dependent
on the plasma membrane proton gradient and pH, similar to the
wild-type allele (Figure 6D). Furthermore, D360A showed
substrate affinity and specificity profiles very similar to the wild-
type protein (see Figure 6A and results not shown). These results
contradicts the participation of D360 as a residue essential for the
binding and symport of H+ and rather supports an indirect role in
substrate translocation, possibly through its interactions with N410
and T405, as shown earlier (see Figure 2).
A363 and G411 have been shown to be critical residues for
transport [9,33]. Noteworthy, specific substitutions of G411 either
immobilize UapA (G411V) [31], or increase 2-fold its apparent V
(G411A, G411V) [9], suggesting that G411 is a key dynamic
element in movements associated with UapA-mediated transport.
Residue R417 has been shown to be important specifically for
increasing uric acid binding affinity [10]. In line with that,
mutation R417G reduces dramatically uric acid binding but
conserves high affinity for xanthine.
The other two residues, V463 and A469, do not seem to be
important for substrate transport per se, but specific substitutions of
them affect significantly UapA specificity [12]. Most interestingly,
none of the above residues is critical for protein turnover or for
substrate binding, as shown by relevant mutations. Thus, all
elements of the proposed substrate trajectory are associated with
mutations that either affect transport rates (apparent V values) or
substrate specificity. This observation is in excellent agreement
with residues lining a cytoplasm-facing trajectory downstream
from the major substrate binding site.
Genetic and Structural Support for a Dynamic Outward-
facing Gate Critical for UapA Specificity
Among the most prominent, genetically selected, specificity
mutations are substitutions of T526 and F528 with aliphatic or
polar amino acid residues (Met and Leu for T526; Ala, Ser, Thr
for F528). These substitutions do not affect the kinetic and
specificity profile of UapA for its natural substrates (uric acid and
xanthine) but confer UapA-mediated low affinity uptake of other
purines and purine analogues with bulky substitutions [11,20].
Based on these finding we have proposed that these two residues
act as elements of a molecular filter or a dynamic gate which
selects which purines can have access to the major substrate
binding site, and in turn, substitutions of T526 and F528 loosen
Figure 5. A xanthine translocation pathway in the cytoplasm-facing UapA model. Residues F155, Q408, E356 and A407 define the major
substrate binding site, whereas T526 and F528 indicate a putative outward-facing gate (see text).
doi:10.1371/journal.pone.0041939.g005
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the selectivity of this gate. In the UapA model built herein, T526
and F528 are located in the outward-facing edge of TMS14,
ideally positioned for defining the entrance of substrates in a
trajectory leading to the major binding site. Does this putative
outward-facing gate also act as a secondary substrate binding site?
Although most evidence supports the existence of a single major
substrate binding site positioned in a central cavity of all
transporter studied, the existence of secondary binding sites in
outward and inward faces of transporters is a recent and strongly
debatable issue [34–41].
To test the possible implication of residues T526 and F528 as
elements of an outward-facing gate and/or a putative secondary
substrate binding site, we performed flexible docking calculations
of xanthine utilizing wide sampling. Our results indicated a
particular binding geometry at a distance from the major substrate
binding domain, which might serve as an individual outward-
facing recognition spot and which includes residues T526 and
F528 (Figure 7A, 7B). More specifically, a small ensemble of poses
with favorable geometries is found to occupy a cavity formed at
the boundary between the extracellular and transmembrane
regions of the protein. In this area, a well defined cleft is formed
between the gate subdomain of the transporter and protruding
helices TMS13 and TMS14. The purine is stabilized there by
hydrogen bonds accommodated by S233, T237, T526 and F528.
It should be mentioned that from a topological perspective that
cavity is simultaneously the most easily accessible from the solvent
and still in very close proximity to the major binding site (distance
between E356 and F528 is only 12 A˚). Thus it might be considered
that the major and a secondary substrate binding site are
interconnected, as a linking path would be easily assumed by
hypothesizing slight movements and rolling of helices TMS4 and
TMS7. This proximity is further supported biochemically in
XanQ where substrate binding protects the alkylation of cysteine
residues genetically positioned in TMS14 [25].
To further confirm the existence of this outward-facing gate and
test whether it also functions as a secondary substrate docking site,
we constructed and analyzed mutations concerning S233 and
T237 and G527, which have not been mutated before. We also
constructed and analyzed the double substitution T526M/F528A.
According to the docking result, substitutions of S233 and T237
would, in principle, enlarge the specificity profile of UapA, similar
to substitutions in T526 and F528, whereas substitutions G527V
would also affect the local architecture and thus loosen the
specificity of UapA. The double substitution T526M/F528A
might also further loosen UapA specificity. Results for the analysis
of these mutations are shown in Figure 6. Ala substitutions of S233
and T237 did not affect at all the plasma membrane localization,
the turnover or the transport kinetic and specificity profile of
UapA, strongly suggesting that these residues are not part of the
outward-facing gate or of a secondary binding site. In contrast,
G527V scored as a loss-of-function mutation, especially at 37uC
(Figure 6A, 6C), apparently due to protein instability and vacuolar
degradation (Figure 6B), whereas T526M/F528A showed, tem-
Figure 6. Functional analysis of new UapA mutations. (A)
Growth tests on purines as sole nitrogen sources at 25 and 37uC. UA
indicates uric acid, AD is adenine, HX is hypoxanthine. As a control,
growth on urea is also shown (UR). Positive (UapA+) and negative
(DUapA) isogenic control strains are also shown. (B) Epifluorescence
microscopy showing in vivo subcellular expression of UapA-GFP mutant
alleles and a wild-type control (UapA+). (C) Comparative initial uptake
rates of 3H-radiolabled xanthine in UapA mutant alleles and a wt
control. 100% is the transport rate in the wt (UapA+). (D) Km values for
functional UapA mutants and wt (UapA+). For details see Materials and
Methods.
doi:10.1371/journal.pone.0041939.g006
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perature-dependent, enlarged UapA specificity, leading to UapA-
mediated growth on adenine or hypoxanthine transport
(Figure 6A), strongly supporting the role of the relevant residues
in the functioning of dynamic selectivity gate. In summary, the
analysis of the new mutations further supports the role of residues
T526, G527 and F528 as elements of an outward-facing dynamic
gate controlling substrate specificity, but fail to provide genetic
support for the presence of a secondary substrate binding in this
gate.
Another outward-facing residue that affects dramatically UapA
specificity is Q113 located in the loop between TMS1 and TMS2
(see Figures 1 and 2). A specific substitution, Q113L, enlarges
UapA specificity similar to mutations concerning T526 and F528.
We did not obtain a docking pose of xanthine close to Q133,
which in fact seems very distant from the both the major substrate
binding site and residues T526 and F528. We do not understand
at present how this residue might affect the specificity of UapA,
but it is not however uncommon in transmembrane proteins that a
mutation might have domino effect on activity.
A Possible Inward-facing Gate?
Besides Q113, T526 and F528, all other randomly selected
mutations which have a prominent effect UapA specificity concern
residue R481 [12]. Substitution of R481 with aliphatic residues
enlarges the specificity of UapA similar to mutations in Q113,
T526 and F528. This residue is located at the border of loop
TMS12–TMS13 with TMS13 (see Figure 1 and 2). We did not
obtain a docking pose of xanthine at this site, which is distantly
located form the major substrate binding site. How is critical for
the specificity of UapA for uric acid or xanthine is not, at present
understood. It might be through a domino effect on the outward-
facing gate or it could define an element of a dynamic inward-
facing gate. We favor the second hypothesis based on two
observations. First, deletion of R481 or a 2 amino acid insertion
(Ala-Gly) immediately upstream from R481 lead to increased,
temperature-dependent, UapA instability and vacuolar turnover,
usually obtained with mutations in dynamic elements of the
transporter [12]. Second, double mutants including R481 and
substitutions in T526 or F528, further loosen the specificity of
UapA, showing that there is an additive effect of outward-and
inward-positioned mutations, which can be more easily rational-
ized if two independent selectivity gates operate at both sides
UapA. Furthermore, despite the fact that R481 is topologically
distant from the cytoplasmic end of the substrate translocation
trajectory defined herein, which is close to R417 (see Figure 5), it
should be taken into account that the UapA model built here is
based on a static inward-facing conformation of UraA and
consequently it should not be excluded that in a putative outward-
facing conformation of UapA, loop TMS12–TMS13 and R481
are proximal to the cytoplasmic end of the substrate translocation
trajectory.
In Search of a Structural Rationale for the Evolution of
Novel Specificities in the NAT Family
In primates NAT members are specific for L-ascorbate/Na+
rather than nucleobases/H+. Other mammals have both NAT
versions, specific for either L-ascorbate or nucleobases [1]. We
modeled and performed docking studies with the rat nucleobase
transporter rSNBT1 and the human L-ascorbate transporter
SVCT2. Results, shown in Figure 8, demonstrate that L-
ascorbate and xanthine dock specifically in a centrally located
binding site in SVCT2 and rSNBT1 respectively, but not vice
versa. The amino acid residues involved in substrate interactions
in rSNBT-1 are identical or highly conserved compared to
those identified in UapA (F124, E347, E397 and S396 in
rSNBT1 corresponding to F155, E356, Q408 and A407 in
UapA. In contrast, in SVCT2, which lacks the critical substrate
binding Gln/Glu residue found in nucleobase-specific NATs
(Q408 in UapA, E397 in rSNBT1), binds ascorbate using F170,
S442, E393 and D397, residues that correspond to F155, A497,
E356 and D360 in UapA. Thus, it is clear that the
‘replacement’ of a Gln/Glu by a Pro residue in the NAT
motif, located in TMS10, is a crucial difference for the shift in
specificity in this family of transporters.
To test whether this difference is sufficient to shift the specificity
of UapA from purines to L-ascorbate we constructed mutant
UapA-A407S/Q408P, and tested its expression, stability and
Figure 7. A putative xanthine secondary docking pose at the extra-cytoplasmic side of TMS14. (A)Detailed view and (B) its relative
position to the primary binding site.
doi:10.1371/journal.pone.0041939.g007
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transport profile in respect to purines and L-ascorbate. Results
included in Figure 6 show that the double mutation does not affect
the expression of a GFP-tagged version of this UapA allele to the
plasma membrane, a very strong indication that the overall folding
of the transporter is not affected. This mutant, however, has lost
any detectable capacity of purine uptake and has not acquired
identifiable uptake of L-ascorbate. This result strongly suggests
that evolution of novel specificities within a transporter family is
not simply a result of local changes in the major substrate binding
site, but might also depend on other elements, such as outward-or
inward-facing gates and molecular filters.
Concluding Remarks
The present work presents a theoretical UapA structural model,
which reveals a number of important aspects concerning how this
transporter selects and transports its substrates. Results derived
from different docking methodologies in conjunction with SAR
modeling, were in very good agreement, thus proposing a highly
consistent model concerning UapA substrate recognition. Obvi-
ously all structural models should be treated with great caution
when used to speculate on function. However, UapA presents a
unique case where a plethora of mutations, including randomly
selected mutations, are available and have been used to
understand function without knowing the structure of the
transporter. Much to our satisfaction, our previous and present
genetic and biochemical data fully support the structural data
proposed in this work, and allowed us to speculate on a solid
experimental ground.
Furthermore, our docking approaches are not only in excellent
agreement with the in vivo specificity profile of UapA, but also
provided a rationale for the difference in substrate specificity
between the rat and the human NAT homologues, the former
being specific for nucleobases and the latter for L-ascorbate. We
have previously proposed that the presence of a Gln or Glu residue
in the NAT motif (Q408 in UapA) is a molecular signature for
predicting whether a NAT protein is specific for nucleobases
rather than L-ascorbate. In L-ascorbate transporters Gln/Glu is
replaced by a Pro residue. Here we provide strong mutational and
structural evidence for this observation.
This work reinforces the novel concept of the existence of
dynamic gates or molecular selectivity filters in specific families of
transporters [2,42,43]. The existence of filters or gates can be
easily reconciled with the generally accepted rocker-switch
mechanism of alternating outward-and inward-facing conforma-
tional states in transporters underlying their functioning [30].
Gating, which introduces occluded and open intermediates in the
outward-and inward-facing conformers, might have evolved to
add extra specificity or to prevent leakage of substrates in the
wrong direction [44].
Our findings further show that specificity of NAT homologues
belonging to evolutionary distant groups, such as fungi and
metazoa might not solely be determined from specific interactions
within a major, centrally located, substrate binding site. When we
genetically constructed a UapA substrate binding site mimicking
that of the human ascorbate transporter SVCT2, we obtained an
apparently inactive UapA transporter. This strongly suggests that
the mutational barrier underlying the specificity shift between
UapA and SVCT2 extends beyond changes in the substrate
binding site and probably includes changes in dynamic elements of
these transporters, including gates and molecular filters, as those
described herein. This observation should be critical in future
efforts to use NAT transporters as specific gateways for developing
targeted antimicrobials, but also for rationally designing in vitro
evolution approaches for understanding how transporters work.
Materials and Methods
Homology Modeling
Homology model building was performed using MODELLER
v.9.8 software [45].
Figure 8. Interactions of NAT proteins with specific substrates. (A) Docking pose of L-ascorbate in SVCT-2 and (B) xanthine on superimposed
rSNBT1 (in pink) and UapA (in blue).
doi:10.1371/journal.pone.0041939.g008
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Protein Preparation
The protein was prepared for the docking calculations using the
Protein Preparation Workflow (Schro¨dinger Suite 2011 Protein
Preparation Wizard) implemented in Scho¨dinger suite and
accessible from within the Maestro program (Maestro, version
9.2, Schro¨dinger, LLC, New York, NY, 2011). Briefly, the
hydrogen atoms were added and the orientation of hydroxyl
groups, Asn, Gln, and the protonation state of His were optimized
to maximize hydrogen bonding. Finally, the ligand2protein
complex was refined with a restrained minimization performed
by Impref utility, which is based on the Impact molecular
mechanics engine (Impact version 5.7, Schro¨dinger, LLC, New
York, NY, 2011) and the OPLS2001 force field, setting a max
rmsd of 0.30. Ligand preparation for docking was performed with
LigPrep (LigPrep, version 2.5, Schro¨dinger, LLC, New York, NY,
2011) application which consists of a series of steps that perform
conversions, apply corrections to the structure, generate ionization
states and tautomers, and optimize the geometries.
Molecular Dynamic Simulations
For the MD simulations Desmond v.3 software was implemented
(Desmond Molecular Dynamics System, version 3.0, D. E. Shaw
Research, New York, NY) [24]. The system was prepared by
embedding the protein in a POPC lipid bilayer, solvating the
membrane by TIP4P explicit water, neutralizing with counterions
and adding 150 mM salt and subsequently following the stepwise
equilibration protocol as developed by Desmond for membrane
proteins. The50 ns simulation was performed in the NPcT ensemble
with Langevin thermostat and barostat and semi isotropic pressure
restraints. All molecular dynamic simulations were run on Cy-tera
HPC facility (http://www.linksceem.eu/ls2/).
Induced Fit Docking
Molecular docking was performed using the Induced Fit
Docking (IFD) protocol [46] (Schro¨dinger Suite 2011 Induced
Fit Docking protocol), which is intended to circumvent the
inflexible binding site and accounts for the side chain or backbone
movements, or both, upon ligand binding. In the first stage of the
IFD protocol, softened-potential docking step, 20 poses per ligand
were retained. In the second step, for each docking pose, a full
cycle of protein refinement was performed, with Prime 1.6 (Prime,
version 3.0, Schro¨dinger, LLC, New York, NY, 2011) on all
residues having at least one atom within 8 A˚ of an atom in any of
the 20 ligand poses. The Prime refinement starts with a
conformational search and minimization of the side chains of
the selected residues and after convergence to a low-energy
solution, an additional minimization of all selected residues (side
chain and backbone) is performed with the truncated-Newton
algorithm using the OPLS parameter set and a surface General-
ized Born implicit solvent model. The obtained complexes are
ranked according to Prime calculated energy (molecular mechan-
ics and solvation), and those within 30 kcal/mol of the minimum
energy structure are used in the last step of the process, redocking
with Glide 5.7 (Glide, version 5.7, Schro¨dinger, LLC, New York,
NY, 2011) using standard precision, and scoring. In the final
round, the ligands used in the first docking step are redocked into
each of the receptor structures retained from the refinement step.
The final ranking of the complexes is done by a composite score
which accounts for the receptor2ligand interaction energy
(GlideScore) and receptor strain and solvation energies (Prime
energy).
Flexible Docking Calculations
Flexible Docking Calculations were performed using Macro-
model 9.9 (MacroModel, version 9.9, Schro¨dinger, LLC, New
York, NY, 2011). As starting structure we used the best pose
derived from IFD calculations for both tautomers of Xanthine
(Xan7 and Xan9). Partial charges were calculated using the Jaguar
Software (Jaguar, version 7.8, Schro¨dinger, LLC, New York, NY,
2011). Docking calculations were performed using 1000 steps or
5000 steps search of the mixed Monte Carlo/Low Mode (MC/
LMOD) [47] search algorithm with a ratio of 0.5 and
OPLSA2005 [48] force field. During the LMOD structural
perturbation, and during the subsequent energy minimization, all
residues within 6.0 A˚ from the ligand were allowed to move freely.
The remaining residues were treated as ‘‘frozen atoms.’’ Addi-
tional structural perturbation was applied for all torsion angles of
the three ‘‘distorted’’ aminoacids, using the TORS command. The
ligand was subjected to explicit translation/rotation with respect to
the binding site via the MOLS command available in Macromodel
9.0. Also a distance-dependent dielectric ‘‘constant’’ of 4r was
used. After each successful run the complex was minimized using
the TNCG algorithm (rmsG ,0.01 kJ/mol A). Unique confor-
mations were stored only if they were within the lowest 50 kJ/mol.
Prgen
Scoring calculations were performed using the PrGen2.1
software according to the following procedure. Theoretical
binding affinities are estimated by evaluating ligand-receptor
interaction energies, ligand desolvation energies and changes in
both ligand-internal energy and ligand internal entropy upon
receptor binding: Ebinding < Eligand-receptor 2 TDSbinding 2
DGsolvation,ligand + DEinternal,ligand. Calculated free energies DGupred
are then obtained by linear regression between experimental free
energy DGuexp and Ebinding. All molecules were superimposed over
the position of Xanthine as derived from IFD calculations.
Solvation energies, entropy corrections and ligand reference
energies were calculated for all ligands after individual minimiza-
tion using specific built-in PrGen 2.1 modules. To determine the
ligand–receptor interaction energy, Eligand-receptor, the program
uses the force field Yeti _ENREF_48 [49]. Binding affinities are
obtained by linear regression between DGu and Ebinding. All
calculations with PrGen 2.1 were run on a Silicon Graphics
Octane.
Media, Strains and Growth Conditions and Construction
of UapA Mutants
Standard complete (CM) and minimal media (MM) for A.
nidulans were used (http://www.fgsc.net). Auxotrophies were
supplemented at the concentrations given in (http://www.gla.ac.
uk/acad/ibls/molgen/aspergillus/supplement.html). Nitrogen
sources were used at the final concentrations: urea 5 mM, uric
acid, adenine or hypoxanthine 0.5 mM. Chemical reagents were
obtained from Sigma St. Louis, MO and from AppliChem
GmbH. A DuapA DuapC DazgA argB2 pabaA1 strain transformed
with plasmid pAN510-GFP, integrated as a single copy in the argB
locus, served as a standard wild type control [for details of this
strains see 9]. pAN510-GFP carries a fully functional uapA gene
fused with the gfp orf to allow for the subcellular localization of
UapA-GFP by epifluorescence microscopy [9,20]. An isogenic
DuapA DuapC DazgA argB2 pabaA1 mutant was the recipient strain
in transformations with mutant uapA alleles which were construct-
ed on vector pAN510-GFP by site-directed mutagenesis according
to the instructions accompanying the Quik-ChangeH Site-Directed
Mutagenesis Kit (Stratagene), using complementary oligonucleo-
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tides carrying the desired substitution (Table S1), Mutations were
confirmed by sequencing. The pAN510-GFP vector allows
selection of transformants based on arginine auxotrophy comple-
mentation [9]. Transformation of A. nidulans was as according to
Koukaki et al. [50]. Transformants expressing intact uapA-gfp
alleles, through single-copy plasmid integration events, were
identified by standard PCR and Southern analysis. Growth tests
were performed at 25uC and at 37uC, pH 6.8.
Standard Nucleic Acid Manipulations
Genomic DNA extraction from A. nidulans was as described.
Plasmid preparation from E. coli strains was done with the
Nucleospin Plasmid kit according to the manufacturer’s instruc-
tions (Macherey-Nagel GmbH). DNA bands were purified from
agarose gels using the Nucleospin ExtractII kit according to the
manufacturer’s instructions (Macherey-Nagel GmbH).
[32P]dCTP-labeled molecules used as uapA or argB specific probes
were prepared using a random hexanucleotide primer kit following
the supplier’s instructions (Takara Bio Inc.) and purified on
MicroSpinTM S-200 HR columns, following the supplier’s
instructions (Roche Applied Science). Labeled [32P]dCTP
(3000 Ci/mmol) was purchased from the Institute of Isotopes
Co., Ltd. Restriction enzymes were from Takara Bio Inc.
Conventional PCR reactions were done with KAPATaq DNA
polymerase (KAPABIOSYSTEMS, USA). Cloning and amplifi-
cation of products were done with Pfx Platinum (Invitrogen) or
PhusionH Flash High-Fidelity PCR MasterMix (New England
Biolabs).
Epifluorescence Microscopy and Transport Kinetic Assays
Samples for fluorescence microscopy were prepared as previ-
ously described [9,14,20]. In brief, the samples were incubated on
coverslips in liquid Minimal Medium supplemented with urea as
nitrogen source for 12–14 h at 25uC, observed on an Axioplan
Zeiss phase-contrast epifluorescent microscope with appropriate
filters, and the resulting images were acquired with a Zeiss MRC5
digital camera using AxioVs40 V4.40.0 software. Images were
then processed with Adobe Photoshop CS2 V9.0.2 software.
Radiolabelled 3H-xanthine (19.6–33.4 Ci/mmol, Moravek Bio-
chemicals, Brea, CA) or 1-14C-Lascorbate (2 mCi/mmol, NEN
Life Sciences Boston, MA) uptake in conidiospores was assayed at
37uC as described before [12,20]. Ki values were calculated from
the Cheng and Prusoff equation: Ki = IC50/(1+L/Km) where L is
the permeant concentration.
Supporting Information
Figure S1 Root mean square deviation (RMSD) calcu-
lation of the Ca-carbons of all helices, recovering
information every 0.25 ns from MD performed for
50 ns.
(TIF)
Figure S2 Docking of xanthine analogues in UapA. (A) 3-
methylxanthine, (B) 8-methylxanthine, (C) 9-methylxanthine, (D)
1-methylxanthine, (E) 2-thioxanthine, (F) 6-thioxanthine, (G) 8-
azaxanthine, (H) hypoxanthine, (I) adenine, (J) guanine. Hydrogen
bonds are depicted with dashed lines. Weak hydrogen bonds are
depicted with thin dashed lines.
(TIF)
Table S1 Forward oligonucleotides used in this study
for construction targeted mutation in uapA. Reverse
primers, complementary to the ones listed bellow, were also used.
(DOC)
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